Drugs / (11C)PE2I
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT03675282 | Aug 2018 → Apr 2024 | Parkinson disease, REM sleep behavior disorder | Weill Medical College of Cornell University | Completed | Missed primary |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | (11C)PE2I | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03675282 ↗ |